MaxCyte, Inc.

AIM:MXCT Rapport sur les actions

Capitalisation boursière : UK£319.5m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

MaxCyte Bilan de santé

Santé financière contrôle des critères 6/6

MaxCyte possède un total de capitaux propres de $221.3M et une dette totale de $0.0, ce qui porte son ratio d'endettement à 0%. Son actif total et son passif total sont $251.5M et de $30.2M.

Informations clés

0%

Ratio d'endettement

US$0

Dette

Ratio de couverture des intérêtsn/a
Argent liquideUS$157.33m
Fonds propresUS$221.26m
Total du passifUS$30.24m
Total des actifsUS$251.50m

Mises à jour récentes de la santé financière

Recent updates

MaxCyte, Inc. (LON:MXCT) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 09
MaxCyte, Inc. (LON:MXCT) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Investors Appear Satisfied With MaxCyte, Inc.'s (LON:MXCT) Prospects As Shares Rocket 27%

May 30
Investors Appear Satisfied With MaxCyte, Inc.'s (LON:MXCT) Prospects As Shares Rocket 27%

Analysts Are Upgrading MaxCyte, Inc. (LON:MXCT) After Its Latest Results

May 10
Analysts Are Upgrading MaxCyte, Inc. (LON:MXCT) After Its Latest Results

Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term

Mar 14
Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Mar 07
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Analysts Have Just Cut Their MaxCyte, Inc. (LON:MXCT) Revenue Estimates By 22%

Oct 07
Analysts Have Just Cut Their MaxCyte, Inc. (LON:MXCT) Revenue Estimates By 22%

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Aug 12
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

MaxCyte, Inc. (LON:MXCT) Analysts Just Slashed This Year's Revenue Estimates By 11%

May 15
MaxCyte, Inc. (LON:MXCT) Analysts Just Slashed This Year's Revenue Estimates By 11%

Investors Don't See Light At End Of MaxCyte, Inc.'s (LON:MXCT) Tunnel And Push Stock Down 28%

May 14
Investors Don't See Light At End Of MaxCyte, Inc.'s (LON:MXCT) Tunnel And Push Stock Down 28%

We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Apr 27
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth

Nov 20
Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Mar 02
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Nov 17
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

We're Not Worried About MaxCyte's (LON:MXCT) Cash Burn

Jul 25
We're Not Worried About MaxCyte's (LON:MXCT) Cash Burn

MaxCyte (LON:MXCT) Shareholders Have Enjoyed A Whopping 545% Share Price Gain

Feb 22
MaxCyte (LON:MXCT) Shareholders Have Enjoyed A Whopping 545% Share Price Gain

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de MXCT ( $175.6M ) dépassent ses passifs à court terme ( $12.3M ).

Passif à long terme: Les actifs à court terme de MXCT ( $175.6M ) dépassent ses passifs à long terme ( $18.0M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: MXCT est sans dette.

Réduire la dette: MXCT n'avait aucune dette il y a 5 ans.


Bilan


Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: MXCT dispose d'une piste de trésorerie suffisante pour plus de 3 ans sur la base de son flux de trésorerie disponible actuel.

Prévisions de trésorerie: MXCT dispose d'une marge de trésorerie suffisante pour plus de 3 ans si le flux de trésorerie disponible continue de diminuer à un taux historique de 22.5 % chaque année


Découvrir des entreprises saines